Condition
Ascending Aortic Dilatation
Total Trials
4
Recruiting
3
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting3
Active Not Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07034430Active Not RecruitingPrimary
Aortic Dilatation Under 5 cm: Genetic Risk Mapping
NCT05739253Recruiting
Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement
NCT06743568Not ApplicableRecruiting
Efficacy of Self-expandable and Balloon-expandable Valves in Patients With Ascending Aortic Dilation
NCT06009588Not ApplicableRecruiting
Comparison of Self- and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement: The AAD-CHOICE
Showing all 4 trials